Skip to Content
Skip to main content
LOGO(small) - Queen's University Belfast
  • Our twitter
  • Our facebook
  • Our
  • Our
SEARCH SEARCH
LOGO(large) - Queen's University Belfast

Wellcome-Wolfson Institute For Experimental Medicine

  • Home
  • Our Research
    • Research Themes
    • Find a PhD Supervisor
  • Our People
    • Key Contacts
    • Academic Staff
    • Fellows
    • Research Staff
    • Technical Staff
    • Administrative/Clerical Staff
    • Emeritus Professors
    • Opportunities
    • Visiting Students
  • Our Place
    • Facilities
    • Seminar Series
    • The Barcroft Lecture
    • Fraser Symposium
    • Green Impact
  • Education and Training
    • Postgraduate Degrees
    • Masters in Experimental Medicine
    • Undergraduate Degrees
    • Summer Student Programme
    • iENGAGE
    • Postdoctoral Development Programme
    • Outreach
  • News
    • WWIEM Newsletter
  • Innovation
  • COVID-19
  • Donate
  • Home
  • Our Research
    • Research Themes
    • Find a PhD Supervisor
  • Our People
    • Key Contacts
    • Academic Staff
    • Fellows
    • Research Staff
    • Technical Staff
    • Administrative/Clerical Staff
    • Emeritus Professors
    • Opportunities
    • Visiting Students
  • Our Place
    • Facilities
    • Seminar Series
    • The Barcroft Lecture
    • Fraser Symposium
    • Green Impact
  • Education and Training
    • Postgraduate Degrees
    • Masters in Experimental Medicine
    • Undergraduate Degrees
    • Summer Student Programme
    • iENGAGE
    • Postdoctoral Development Programme
    • Outreach
  • News
    • WWIEM Newsletter
  • Innovation
  • COVID-19
  • Donate
  • Our twitter
  • Our facebook
  • Our
  • Home
  • Wellcome-Wolfson Institute For Experimental Medicine
  • News

News

Queen's University researchers make pneumonia breakthrough

15 June, 2018

A chance conversation between researchers at Queen’s University Belfast led to their combined expertise in developing a ground-breaking approach for the treatment of pneumonia.

The research team’s findings have recently been published in the prestigious leading Journal of Controlled Release.

Pneumonia is a serious inflammatory condition of the lungs, which is responsible for over 5% of all deaths in the UK each year, equivalent to over 3.2 million and also remains the leading infectious cause of death among children under five worldwide.

One of the most common causes of pneumonia is lung infection with the bacteria Klebsiella pneumoniae, the very bacteria that Professor Jose Bengoechea, Centre Director at the Wellcome-Wolfson Institute for Experimental Medicine at Queen’s University has spent much of his research career studying.

It was a chance conversation between Professor Bengoechea, Professor Cliff Taggart, a researcher at the Wellcome-Wolfson Institute for Experimental Medicine and their colleague Professor Chris Scott at the Centre for Cancer Research and Cell Biology that led to the discovery of this new groundbreaking treatment for pneumonia.

During this conversation the researchers realised that an idea Professor Scott was developing for cancer treatment could also be used for tackling deadly Klebsiella infections.  

Professor Bengoechea explains: “This microbe is a particularly difficult bug to treat due to increasing number of isolates resistant to virtually all currently available antibiotics.

“It actually hides in the lung by sneaking inside immune cells, making it exceptionally hard to access with antibiotics.  This hidden infection can then re-emerge and cause pneumonia in patients”.

It was the discussion of Professor Scott’s lab work using nanotechnology to target chemotherapy directly into cancer cells when the researchers realised that the same targeted approach could be used to get antibiotics directly to the deadly bacteria lurking in infected immune cells.

 Professor Scott explains: “This is a perfect example of how thinking out of the box and combining very different expertise, you can have an eureka moment!

“These exciting research findings are very much in line with the research ethos of the University, which is centred on global challenges.

“Pneumonia remains a global health emergency.  By developing this treatment that has proven to tackle this deadly strain of bacteria, our research partnership could change the lives of people across the world.”

The Queen's team are continuing further research within the next 5 years to achieve a better understanding of how best to treat patients with pneumonia with this specialised technology.

Media inquiries

Media inquiries to Sian Devlin at Queen’s Communications Office on: s.devlin@qub.ac.uk or tel: 028 9097 5292.


Share
Latest News
  • Spotlight on COVID-19 Research at WWIEM
    10 February, 2021
  • First COVID-19 vaccine trial in Northern Ireland finds new vaccine to be highly effective
    29 January, 2021
  • Queen’s-led cell therapy clinical trial completes recruitment of ICU patients with COVID-19
    21 January, 2021
  • Queen’s University to research how COVID-19 damages blood vessels
    7 January, 2021
  • UK-wide study shows antibodies persist for at least two months in children who have had COVID-19
    20 November, 2020
In This Section
News
  • WWIEM Newsletter
Queen's University Belfast - Logo (small)
Contact Us

Wellcome-Wolfson Institute For Experimental Medicine

School of Medicine, Dentistry and Biomedical Sciences
Queen's University Belfast
97 Lisburn Road
Belfast
BT9 7BL

Tel: (+44) 028 9097 1643
Email: wwiem@qub.ac.uk

Quick Links

  • Home
  • Our Research
  • Our People
  • Our Place
  • Education and Training

 

© Queen's University Belfast 2021
Privacy and cookies
Website accessibility
Freedom of information
Modern slavery statement
Equality, Diversity and Inclusion